MIRM
Price
$40.43
Change
+$0.81 (+2.04%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
2B
6 days until earnings call
RARE
Price
$37.64
Change
+$0.33 (+0.88%)
Updated
Apr 24 closing price
Capitalization
3.53B
6 days until earnings call
Ad is loading...

MIRM vs RARE

Header iconMIRM vs RARE Comparison
Open Charts MIRM vs RAREBanner chart's image
Mirum Pharmaceuticals
Price$40.43
Change+$0.81 (+2.04%)
Volume$9.91K
Capitalization2B
Ultragenyx Pharmaceutical
Price$37.64
Change+$0.33 (+0.88%)
Volume$1.34M
Capitalization3.53B
MIRM vs RARE Comparison Chart
Loading...
MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MIRM vs. RARE commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIRM is a StrongBuy and RARE is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (MIRM: $40.47 vs. RARE: $37.64)
Brand notoriety: MIRM and RARE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MIRM: 57% vs. RARE: 154%
Market capitalization -- MIRM: $2B vs. RARE: $3.53B
MIRM [@Biotechnology] is valued at $2B. RARE’s [@Biotechnology] market capitalization is $3.53B. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MIRM’s FA Score shows that 1 FA rating(s) are green whileRARE’s FA Score has 0 green FA rating(s).

  • MIRM’s FA Score: 1 green, 4 red.
  • RARE’s FA Score: 0 green, 5 red.
According to our system of comparison, MIRM is a better buy in the long-term than RARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MIRM’s TA Score shows that 5 TA indicator(s) are bullish while RARE’s TA Score has 5 bullish TA indicator(s).

  • MIRM’s TA Score: 5 bullish, 4 bearish.
  • RARE’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RARE is a better buy in the short-term than MIRM.

Price Growth

MIRM (@Biotechnology) experienced а +3.50% price change this week, while RARE (@Biotechnology) price change was +5.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

MIRM is expected to report earnings on Jul 31, 2025.

RARE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RARE($3.53B) has a higher market cap than MIRM($2B). MIRM YTD gains are higher at: -2.128 vs. RARE (-10.530). MIRM has higher annual earnings (EBITDA): -48.97M vs. RARE (-469M). RARE has more cash in the bank: 610M vs. MIRM (280M). RARE has less debt than MIRM: RARE (40.3M) vs MIRM (318M). RARE has higher revenues than MIRM: RARE (560M) vs MIRM (337M).
MIRMRAREMIRM / RARE
Capitalization2B3.53B57%
EBITDA-48.97M-469M10%
Gain YTD-2.128-10.53020%
P/E RatioN/AN/A-
Revenue337M560M60%
Total Cash280M610M46%
Total Debt318M40.3M789%
FUNDAMENTALS RATINGS
RARE: Fundamental Ratings
RARE
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
79
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MIRMRARE
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 17 days ago
68%
Bearish Trend 17 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZUOX15.530.34
+2.24%
Lazard US Equity Focus Open
APDKX49.510.22
+0.45%
Artisan International Value Advisor
CLXRX55.84N/A
N/A
Columbia Large Cap Index Inst2
FEQJX12.39N/A
N/A
Fidelity Advisor Hedged Equity Fund I
ERLGX17.51N/A
N/A
Eaton Vance Atlanta Capital Fcs Gr R6

MIRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, MIRM has been loosely correlated with GERN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MIRM jumps, then GERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRM
1D Price
Change %
MIRM100%
+2.15%
GERN - MIRM
41%
Loosely correlated
+2.16%
FHTX - MIRM
37%
Loosely correlated
-4.49%
CYCC - MIRM
36%
Loosely correlated
-0.52%
RARE - MIRM
35%
Loosely correlated
+0.88%
ZNTL - MIRM
35%
Loosely correlated
+0.67%
More